Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group

NCT01802814 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT01802814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01802814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2014
Completion date
July 31, 2023
Enrollment
700 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia (all)